The Broad Foundation
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
45.5%
5 terminated/withdrawn out of 11 trials
54.5%
-32.0% vs industry average
18%
2 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
Role: collaborator
ASTIC Autologous Stem Cell Transplantation for Crohn's Disease
Role: collaborator
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Role: collaborator
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
Role: collaborator
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
Role: collaborator
The Effects of Naltrexone on Active Crohn's Disease
Role: collaborator
Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease
Role: collaborator
Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease
Role: collaborator
A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease
Role: collaborator
Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity
Role: collaborator
Fecal Microbiota Transplantation for Ulcerative Colitis
Role: collaborator
All 11 trials loaded